T Cell Senescence And Exhaustion: Molecular Mechanisms And Immune Rejuvenation For Cancer Immunotherapy
Our immune system’s T cells are crucial for fighting cancer, but their effectiveness can be hampered by two major issues: exhaustion and senescence. Exhaustion occurs when T cells are constantly exposed to cancer cells, making them tired and less able to attack the tumor. Think of it like a soldier fighting a prolonged battle without rest, eventually losing their strength and ability to fight effectively. Senescence, on the other hand, is a more permanent state where T cells essentially “age” prematurely or stop dividing, losing their ability to proliferate and perform their anti-cancer functions. This is akin to a soldier becoming too old or injured to continue fighting.
Both of these conditions create significant barriers for modern cancer treatments like immunotherapy, which rely on robust T cell activity. When T cells are exhausted or senescent, treatments become less effective and their benefits don’t last as long. However, new research is shedding light on the molecular reasons behind these T cell dysfunctions. Scientists are now exploring innovative ways to “rejuvenate” these T cells. This includes approaches like using immune checkpoint blockers, which essentially remove the “brakes” on T cells, allowing them to regain their fighting power. Other strategies involve engineering T cells, such as creating “armored” CAR-T cells that are more resistant to exhaustion, or using “senolytic” therapies to selectively remove the senescent, aged T cells. By understanding and overcoming these challenges, we can unlock more durable and transformative cancer immunotherapies, helping the body fight cancer more effectively for longer periods.
Source: link to paper